- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03934294
Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients
Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients: A Protocol for Double Blind Randomized Control Trial
Background: Head and neck cancer patients are in high risk to suffer from malnourishment, a risk that increase in postoperative condition and with the use of enteral nutrition (EN). Until now patients who are suffering from indigestion in the ICU received treatment in the form of prokinetic drugs, drags that can lead to serious side effects and only can partially improve digestion. Acupuncture was used successfully in several clinical trials to improve postoperative indigestion in cancer patients without any reported adverse events. This study aims is to design a double blind settings in order to investigate acupuncture effect in combination of prokinetic drugs in the prevention of indigestion in postoperative oral and hypo-pharyngeal cancer patients in the Intensive Care Unit (ICU).
Methods: Single center, double blind randomize control trial will compare between two equal groups. A total of 28 patients that will meet the inclusion criteria: Age 30-80, Post plastic surgery for oral cancer or hypo-pharyngeal cancer, Apache score below 20 needed EN. Patients will be randomly divided into specific acupuncture (ACU) or non-specific acupuncture (CON) for 3 treatments in 3 days by a blind acupuncturist along with prokinetic drugs. The main outcome measurement will be the amount of days a patient need to reach Total Energy Expenditure (TEE).
Expected outcome: The results will shed light on the effectiveness and safety of acupuncture in a double blind design for posts-surgery ICU cancer patients. In addition, the study presents a revolutionary double blind design that if will prove as successful might influence the way double blind acupuncture studies are performed today.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Head and neck cancer patients are in high risk to suffer from malnourishment, a risk that increase in postoperative condition and with the use of enteral nutrition (EN). Until now patients who are suffering from indigestion in the ICU received treatment in the form of prokinetic drugs, drags that can lead to serious side effects and only can partially improve digestion. Acupuncture was used successfully in several clinical trials to improve postoperative indigestion in cancer patients without any reported adverse events. This study aims is to design a double blind settings in order to investigate acupuncture effect in combination of prokinetic drugs in the prevention of indigestion in postoperative oral and hypo-pharyngeal cancer patients in the Intensive Care Unit (ICU).
Methods: Single center, double blind randomize control trial will compare between two equal groups. A total of 28 patients that will meet the inclusion criteria: Age 30-80, Post plastic surgery for oral cancer or hypo-pharyngeal cancer, Apache score below 20 needed EN. Patients will be randomly divided into specific acupuncture (ACU) or non-specific acupuncture (CON) for 3 treatments in 3 days by a blind acupuncturist along with prokinetic drugs. The main outcome measurement will be the amount of days a patient need to reach his Total Energy Expenditure (TEE).
Expected outcome: The results will shed light on the effectiveness and safety of acupuncture in a double blind design for posts-surgery ICU cancer patients. In addition, the study presents a revolutionary double blind design that if will prove as successful might influence the way double blind acupuncture studies are performed today.
Other information: The study will be conducted in the surgical ICU department, of china medical university hospital, Taichung 404, Taiwan. The study in conducted on stable ICU patients and is anticipated to have a minimum risk for adverse events. Patients enrollment and data collection will start immediately after china medical hospital research ethics committee approval. The study expected completion time: June 2021
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Taichung
-
Taichung City, Taichung, Taiwan, 40402
- surgical and burn intensive care departments and the plastic surgical department of China Medical University Hospital in Taichung city, Taiwan.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 30-80
- Apache score below 20
- Patients needed EN
- Post plastic surgery, including oral cancer or hypo-pharyngeal cancer
Exclusion Criteria:
- Coagulopathy,
- prolong prothrombin time (PPT) activated partial thromboplastin time (aPTT) more then 4 times
- Thrombocytopenia - low platelet count
- Clinically unstable: receiving two inotropic agents or Fraction of inspired Oxygen (FiO2) >70%
- Estimated ICU stay - less than 3 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment group: specific acupuncture group(Acu)
In addition to routine ICU treatments, patients in the specific acupuncture group will also receive daily bilateral traditional Chinese medicine style acupuncture on the following acupuncture points: ST36 (Zu San Li), ST37 (Shangjuxu), ST39 (Xiajuxu), PC6 (Nei Guan) and LI4 (He Gu). The acupoints indications in this group are specific to treat indigestion related conditions. The treatment will take place once a day, over three days, for a total of three treatments. A total of 10 Needles will be used in each session Acupuncture treatment will be performed with sterile needles manufactured by "Yu Kuang" acupuncture needles 40mm with 30G. Acupuncture doctor will disinfect the acupoints with alcohol and will perform acupuncture on the marked points with needle Needle retention time will be 30 minutes. The needles will be withdrawn by acupuncture doctor. |
In addition to routine ICU treatments, patients in the specific acupuncture group will also receive daily bilateral traditional Chinese medicine style acupuncture on the following acupuncture points: ST36 (Zu San Li), ST37 (Shangjuxu), ST39 (Xiajuxu), PC6 (Nei Guan) and LI4 (He Gu).
The acupoints indications in this group are specific to treat indigestion related conditions.
The treatment will take place once a day, over three days, for a total of three treatments.
A total of 10 Needles will be used in each session Acupuncture treatment will be performed with sterile needles manufactured by "Yu Kuang" acupuncture needles 40mm with 30G.
Other Names:
Patients in all groups will receive Metoclopramide 10mg/ per 8 hours in the case of poor digestion, alongside the individualized drug treatment prescribed by the ICU medical doctor as per individual patient needs.
Other Names:
|
Placebo Comparator: Control group: non-specific acupuncture group (Con-Acu)
Patients' in the non-specific acupuncture group (Con-Acu) will receive routine ICU treatment as well as a total of 3 daily non digestion related Traditional Chinese medicine style acupuncture treatments at the following acupoints: LI 15 (Jianyu), SJ 14 (JianLiao) LU3 (Tianfu), GB35 (Yangjiao), BL 59 (Fuyang). The selected control points are not indicated for the treatment of digestion related pathologies, and are not reported to improve digestive function. Acupuncture doctor 1 will disinfect the marked acupoints with alcohol and will perform acupuncture on the marked points. Needle retention time will be 30 minutes. The needles will be withdrawn by acupuncture doctor |
Patients in all groups will receive Metoclopramide 10mg/ per 8 hours in the case of poor digestion, alongside the individualized drug treatment prescribed by the ICU medical doctor as per individual patient needs.
Other Names:
Patients' in the non-specific acupuncture group (Con-Acu) will receive routine ICU treatment as well as a total of 3 daily non digestion related Traditional Chinese medicine style acupuncture treatments at the following acupoints: LI 15 (Jianyu), SJ 14 (JianLiao) LU3 (Tianfu), GB35 (Yangjiao), BL 59 (Fuyang).
The selected control points are not indicated for the treatment of digestion related conditions, and are not reported to improve digestive function.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to reach Total Energy Expenditure
Time Frame: Up to 1 month
|
Number of days in takes for each patient to achieve the Total Energy Expenditure
|
Up to 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Amount of prokinetic drugs prescribed
Time Frame: Up to 1 month
|
Secondary outcomes measures are the amount of prokinetic drugs prescribed by the ICU doctor in total dosage
|
Up to 1 month
|
The need of naso-jejunal feeding tube
Time Frame: Up to 1 month
|
After 5 days of conservative treatment for the poor digestion (naso-gastric tube drainage of more than 500ml per day or severe diarrhea of more than 1000 ml per day)
|
Up to 1 month
|
The need of parental nutrition
Time Frame: up to 1 month
|
In patients who cannot digest with daily naso-gastric tube drainage of more than 500ml per day or severe diarrhea of more than 1000 ml per day
|
up to 1 month
|
Incidents of vomits
Time Frame: Up to 1 month
|
Incidents of vomits in total number of times and volume in micro liters
|
Up to 1 month
|
Albumin blood levels
Time Frame: Up to 1 month
|
Patient's Albumin blood levels will help to assets patient's nutrition status
|
Up to 1 month
|
Total ICU stay
Time Frame: Up to 23 month
|
Total ICU stay in days
|
Up to 23 month
|
Total hospital stay
Time Frame: Up to 23 month
|
Total hospital stay in days
|
Up to 23 month
|
Total mechanical ventilation in days
Time Frame: Up to 23 month
|
A day of mechanical ventilation is at least 6 hours of mechanical ventilation in one day
|
Up to 23 month
|
Total mortality
Time Frame: Up to 23 month
|
In case of mortality ,total mortality will be compered between the two groups
|
Up to 23 month
|
Incidents of diarrhea
Time Frame: Up to 1 month
|
Incidents of diarrhea in number of times and volume in micro liters
|
Up to 1 month
|
Incidents of constipation
Time Frame: Up to 1 month
|
No stool passage in 3 days will be considered as constipation
|
Up to 1 month
|
Incidents of nausea
Time Frame: Up to 1 month
|
Incidents of nausea in number of times , measured by patient complains
|
Up to 1 month
|
Incidents of gastrointestinal bleeding
Time Frame: Up to 1 month
|
Positive occult blood test of the naso-gastric tube drainage and in the stool
|
Up to 1 month
|
Incidents of fever episodes
Time Frame: Up to 1 month
|
Body temperature more than 38 degrees Celsius
|
Up to 1 month
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pei-Yu Kao, M.D., China Medical University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Neoplasms
- Neoplasms by Site
- Disease Attributes
- Otorhinolaryngologic Neoplasms
- Head and Neck Neoplasms
- Pharyngeal Diseases
- Stomatognathic Diseases
- Otorhinolaryngologic Diseases
- Mouth Diseases
- Critical Illness
- Mouth Neoplasms
- Hypopharyngeal Neoplasms
- Pharyngeal Neoplasms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Antiemetics
- Gastrointestinal Agents
- Dopamine Agents
- Dopamine D2 Receptor Antagonists
- Dopamine Antagonists
- Metoclopramide
Other Study ID Numbers
- CMUH108-REC2-037(AR-1)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypopharyngeal Cancer
-
Wake Forest University Health SciencesTerminatedHead and Neck Cancer | Stage I Laryngeal Cancer | Stage II Laryngeal Cancer | Stage I Hypopharyngeal Cancer | Stage I Oropharyngeal Cancer | Stage II Hypopharyngeal Cancer | Stage II Oropharyngeal Cancer | Stage III Hypopharyngeal Cancer | Stage III Laryngeal Cancer | Stage III Oropharyngeal Cancer | Stage... and other conditionsUnited States
-
University Hospital OstravaRecruitingLaryngeal Disease | Laryngeal Lesions | Hypopharyngeal Lesions | Suspected Laryngeal Cancer | Suspected Hypopharyngeal Cancer | Proven Laryngeal Cancer | Proven Hypopharyngeal CancerCzechia
-
Chinese PLA General HospitalRecruiting
-
Samsung Medical CenterCompletedHypopharyngeal CancerKorea, Republic of
-
The Second People's Hospital of SichuanBiotech Pharmaceutical Co., Ltd.UnknownHypopharyngeal Cancer | Oropharyngeal CancerChina
-
Sun Yat-sen UniversityRecruitingHypopharyngeal Cancer | Immunotherapy | Induction ChemotherapyChina
-
University of Alabama at BirminghamCompletedHead and Neck Cancer | Hypopharyngeal Cancer | Oropharyngeal Cancer | Upper Aerodigestive Tract NeoplasmsUnited States
-
Sun Yat-sen UniversityRecruitingHypopharyngeal CancerChina
-
Fudan UniversityShanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Ninth People's Hospital... and other collaboratorsRecruitingHypopharyngeal Cancer | Larynx CancerChina
-
Fudan UniversityRecruitingLaryngeal Cancer | Hypopharyngeal CancerChina
Clinical Trials on Specific acupuncture group
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); United States Department of Defense; National...RecruitingLung Cancer | Cancer of ThoraxUnited States
-
Beijing Hospital of Traditional Chinese MedicineUnknownSubjective Cognitive Decline | Subjective Cognitive ComplaintChina
-
Guang'anmen Hospital of China Academy of Chinese...Unknown
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaCompletedStage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral NeuropathyUnited States
-
Hadassah Medical OrganizationCompletedComplete Tear, Knee, Anterior Cruciate Ligament | Patellar TendonitisIsrael
-
China Medical University HospitalUnknown
-
The Third Affiliated hospital of Zhejiang Chinese...Recruiting
-
Shanghai Institute of Acupuncture, Moxibustion...CompletedCrohn's Disease | CAMChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead And Neck CancerUnited States, China
-
Albert Einstein College of MedicinePatient-Centered Outcomes Research Institute; Montefiore Medical Center; Mount... and other collaboratorsCompletedOsteoarthritis | Back Pain | Chronic Pain | Neck PainUnited States